| Response to intravenous lidocaine in a patient with SUNCT syndrome. | |
| | |
MedLine Citation:
|
PMID: 19438923 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) syndrome represents a serious therapeutic and diagnostic challenge, since it is usually refractory to most drugs and lacks biological markers. Response to intravenous lidocaine administration has been reported in some patients while it has failed in others. We report a patient with SUNCT syndrome who showed a clear-cut and consistent response to intravenous lidocaine therapy, which proved superior to placebo in a single-blinded fashion. Intravenous lidocaine should be considered in all patients with SUNCT syndrome. Response to this therapy could represent a diagnostic tool. |
| | |
Authors:
|
A Martinez Arroyo; X Romero Durán; M Gomez Beldarrain; A Pinedo; J C García-Moncó |
Related Documents
:
|
1007933 - Delusional hyper-identifications of the frégoli type. organic pathogenetic contributors. 20706703 - Intracellular ros level is increased in fibroblasts of triple a syndrome patients. 16263633 - Doppler ultrasonographic detection of nutcracker syndrome in a young child with intussu... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Cephalalgia : an international journal of headache Volume: 30 ISSN: 1468-2982 ISO Abbreviation: Cephalalgia Publication Date: 2010 Jan |
Date Detail:
|
Created Date: 2010-09-07 Completed Date: 2010-12-28 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8200710 Medline TA: Cephalalgia Country: England |
Other Details:
|
Languages: eng Pagination: 110-2 Citation Subset: IM |
Affiliation:
|
Servicio de Neurología, Hospital de Galdacano, Vizcaya, Spain. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Anesthetics, Local / administration & dosage* Humans Injections, Intravenous Lidocaine / administration & dosage* Male Recurrence Remission Induction SUNCT Syndrome / drug therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Anesthetics, Local; 137-58-6/Lidocaine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Headaches due to giant cell arteritis following herpes zoster ophthalmicus in an elderly patient.
Next Document: Application of ICHD-II criteria for headaches in a TMJ and orofacial pain clinic.